Form CORRESP - Correspondence:
SEC Accession No. 0001493152-21-009315
Filing Date
2021-04-21
Accepted
2021-04-21 06:15:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 11305
  Complete submission text file 0001493152-21-009315.txt   12489
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 7389 Services-Business Services, NEC